drug for Hyperlipidemia and Mixed Dyslipidemia which Slowing of the Progression of Atherosclerosis
Hyperlipidemia and Mixed Dyslipidemia. - Pediatric Patients with Familial Hypercholesterolemia.
Key Benefits:
• Tablets contain: Rosuvastatin 5 mg
• Indication: - Hyperlipidemia and Mixed Dyslipidemia. - Pediatric Patients with Familial Hypercholesterolemia. - Hypertriglyceridemia. - Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia). - Adult Patients with Homozygous Familial Hypercholesterolemia. - Slowing of the Progression of Atherosclerosis. - Primary Prevention of Cardiovascular Disease
• Contraindication: - Patients with a known hypersensitivity to any component of this product. - Patients with active liver disease. - Pregnancy. - Lactation
Attributes
Medical Attributes
Active Ingredient:
Rosuvastatin
Product Content
How to Use:
Recommended dose in adults is 5 to 40 mg orally once daily.
The usual starting dose is 10 to 20 mg once daily.
The usual starting dose in adult patients with homozygous familial hypercholesterolemia is 20 mg once daily.
The maximum dose of 40 mg should be used only for those patients who have not achieved their LDL-C goal utilizing the 20 mg dose.
It can be administered as a single dose at any time of day, with or without food.
The tablet should be swallowed whole.
The recommended dose in pediatrics is 5 to 10 mg orally once daily in patients 8 to less than 10 years of age, and 5 to 20 mg orally once daily in patients 10 to 17 years of age.
In homozygous familial hypercholesterolemia, the recommended dose is 20 mg orally once daily in patients 7 to 17 years of age.
The link to Deconadal 20mg 21 Film Coated Tablet has been copied